首页> 美国卫生研究院文献>Molecular Syndromology >Prolidase Deficiency in a Mexican-American Patient Identified by Array CGH Reveals a Novel and the Largest PEPD Gene Deletion
【2h】

Prolidase Deficiency in a Mexican-American Patient Identified by Array CGH Reveals a Novel and the Largest PEPD Gene Deletion

机译:阵列CGH鉴定的墨西哥裔美国人患者中的脯氨酸酶缺乏症揭示了一种新颖且最大的PEPD基因缺失

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prolidase deficiency (PD) is a rare genetic disorder caused by mutations in the peptidase D (PEPD) gene, affecting collagen degradation. Features include lower extremity ulcers, facial dysmorphism, frequent respiratory infections, and intellectual disability, though there is significant intra- and interfamilial variability. Twenty-eight mutations have been previously reported, all either small deletions/duplications or point mutations discovered by enzyme or DNA assays. PD has been reported in patients of various ethnic backgrounds, but never in the Mexican-American population. We describe the first Mexican-American patient with PD, who presented with typical facial features, developmental delay, microcephaly, and xerosis. Chromosome microarray analysis (CMA) revealed a homozygous deletion in the region of 19q13.11, estimated to be between 124.79 and 195.72 kb in size, representing the largest PEPD gene deletion reported to date and the first discovered by CMA.
机译:脯氨酸蛋白酶缺乏症(PD)是一种罕见的遗传病,由肽酶D(PEPD)基因的突变引起,影响胶原蛋白的降解。特征包括下肢溃疡,面部畸形,频繁呼吸道感染和智力障碍,尽管家庭内部和家庭之间存在显着差异。先前已经报道了28种突变,所有小缺失/重复或通过酶或DNA分析发现的点突变。在不同种族背景的患者中都有PD的报道,但在墨裔美国人中从未见过。我们描述了首位墨西哥裔PD患者,该患者表现出典型的面部特征,发育迟缓,小头畸形和干燥症。染色体微阵列分析(CMA)显示在19q13.11区域纯合缺失,估计大小介于124.79至195.72 kb之间,代表迄今为止报道的最大PEPD基因缺失,也是CMA首次发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号